SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids

Abstract Background Targeting viral cell entry proteins is an emerging therapeutic strategy for inhibiting the first stage of SARS-CoV-2 infection. In this study, 106 bioactive terpenoids from African medicinal plants were screened through molecular docking analysis against human angiotensin-convert...

全面介紹

書目詳細資料

Principais autores:	Gideon A. Gyebi, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Olalekan B. Ogunro, Adegbenro P. Adegunloye, Saheed O. Afolabi
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2021-08-01
叢編:	Journal of Genetic Engineering and Biotechnology
主題:	SARS-CoV-2 ACE2 TMPRSS2 Spike protein Terpenoids Abietane diterpenes: Molecular docking
在線閱讀:	https://doi.org/10.1186/s43141-021-00209-z
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!